Related Experiment Video
Updated: May 30, 2026
07:09
A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells
Published on: July 31, 2012
21.3K
Engineering an optimized expression operating unit for improved recombinant protein production in Escherichia coli
Sara P O Santos1, Luis Fabian S Garcés1, Filipe S R Silva1
1Institute of Health Sciences, Federal University of Bahia, Salvador, BA, Brazil.
Protein Expression and Purification
|August 9, 2022
Summary
Engineered a novel expression operating unit (EOU) for enhanced recombinant protein production in E. coli. This synthetic biology approach utilizes a modified T7 promoter for higher yields of proteins like superfolder GFP.
Area of Science:
- Synthetic biology
- Molecular biology
- Biotechnology
Background:
- Traditional recombinant protein production in E. coli relies on optimizing existing expression vectors.
- Synthetic biology enables the design of novel, modular vectors for tunable protein expression.
Purpose of the Study:
- To engineer a new expression operating unit (EOU) for enhanced recombinant protein production in E. coli.
- To develop a novel T7 promoter variant with increased transcriptional activity.
Main Methods:
- Combinatorial assembly of standardized genetic elements (promoter, operator, RBS, etc.) into a 938 bp EOU.
- Construction of a T7 promoter variant with 1.7-fold higher activity than wild type.
- Testing the EOU in E. coli BL21(DE3) for superfolder GFP (sfGFP) production.
Main Results:
- The novel EOU demonstrated improved sfGFP production (70.62 RFU) compared to a control vector (59.68 RFU).
- Higher yields of purified soluble recombinant sfGFP were achieved using the new EOU (188 mg/L vs. 108 mg/L).
- The EOU performed consistently across different plasmid backbones (pOPT1.0/AmpR and pOPT2.0/CmR).
Conclusions:
- The engineered EOU, featuring a high-activity T7 promoter variant, significantly enhances recombinant protein production in E. coli.
- This modular synthetic biology approach offers a powerful tool for optimizing protein yields.
- The developed EOU is versatile and effective across different plasmid contexts.
Related Concept Videos
01:22Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...